Truist Financial’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,238	Closed	-$240K	–	2690
2023 Q1	$240K	Sell	2,238 -1,711	-43%	-$184K	﹤0.01%	2323
2022 Q4	$434K	Buy	3,949 +424	+12%	+$46.6K	﹤0.01%	2055
2022 Q3	$208K	Buy	+3,525	New	+$208K	﹤0.01%	2276